Translational Medicine

Translational Medicine
Open Access

ISSN: 2161-1025

+44 1223 790975

Lincoln Nadauld

Lincoln Nadauld

Stanford University School of Medicine USA

Dr. Lincoln Nadauld isthe  head of new cancer genomics department at Intermountain Healthcare’s first in-house cancer genomic program. Dr. Nadauld attended Brigham Young University for his undergraduate degree and went on to complete medical and doctoral degrees (MD/PhD) followed by internship and residency at the University of Utah. His doctoral dissertation focused on the molecular genetics of colon cancer. He completed a fellowship in medical oncology at Stanford University where he remained as faculty at the Stanford School of Medicine focusing on cancer genomics and personalized cancer medicine. While at Stanford, he helped to develop technologies that identify DNA changes in cancer to predict whether or not a targeted cancer drug might be effective for a specific patient. Last year Dr. Nadauld was awarded the prestigious Young Investigator Award by the American Society of Clinical Oncology and the Career Development Award of the National Cancer Institute.
Research Interest
Cancer research, Genomics, Oncology

Relevant Topics